Healthcare Industry News: Quick-Med Technologies
News Release - January 14, 2014
Sarasota Medical Products to License Stay-Fresh(R) Antimicrobial Technology for Use in Ostomy and Wound Care ProductsGAINESVILLE, FL--(Healthcare Sales & Marketing Network) - Quick-Med Technologies, Inc. (QMDT) (QMDT), a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that it has licensed its Stay Fresh® technology to Sarasota Medical Products (SMP) for use in Hydrocolloids in SMP's Ostomy and Advanced Wound Care product lines.
"We are very excited to enter this new product segment of hydrocolloids with a partner that is close to home, manufacturing high quality wound care products for global distribution. Our antimicrobial technology will greatly expand the number of patients we can provide with safe, effective antimicrobial products in support of infection prevention and control programs. Our technologies are specifically designed to be effective against resistant organisms like MRSA, and to prevent new resistant bacteria from emerging" said Bernd Liesenfeld, Quick-Med's President. This is the initial commercial application of Quick-Med's newest Stay Fresh format: an antimicrobial superabsorbent powder (SAP) that can be directly substituted for a conventional SAP to provide strong and durable antimicrobial activity in applications including health care and hygiene.
"Hydrocolloids are excellent at maintaining the correct moisture balance to optimize wound closure and healing," notes Professor Gregory Schultz, Director of the Institute for Wound Research and Professor of Obstetrics and Gynecology at the University of Florida. "Stay Fresh antimicrobial activity is based on peroxide, which is the chemical mechanism utilized by the body's own neutrophils to kill invading pathogens, and therefore provides optimum biological safety."
"Sarasota Medical Products manufactures a broad array of premium quality ostomy and advanced wound care products that will now include Quick-Med's Stay Fresh® antimicrobial technology," said Dr. Walt F Leise III, SMP's CEO and President. Sarasota Medical provides product to these markets under a broad range of private labels. The US market for advanced wound care is growing from $3.4 billion in 2010 to an expected $4.6 billion by 2016, and Hydrocolloids represented approximately $800M of the AWC market in 2011.
About Stay Fresh
Stay Fresh is Quick-Med's newest technology platform. This technology is based on hydrogen peroxide -- a well known consumer antimicrobial product that is commonly used in households for disinfecting cuts, scrapes, toothbrushes and more. Hydrogen peroxide is also produced by human cells to combat invasive bacteria, and is a naturally occurring preservative component of milk and honey. EPA has registered Stay Fresh to be utilized to protect a broad selection of treated goods for consumer use, including textiles, decorative fabrics, and functional fabrics such as filters and carpets. FDA has also granted clearance to market an antibacterial medical textile based on Stay Fresh Technology. The Stay Fresh technology offerings provided by Quick-Med are expanding continuously, with development of additional applications including antimicrobial surface treatments, and superabsorbent antimicrobial powders to complement the range of products that are already cleared for consumer use under EPA or FDA jurisdiction.
About Quick-Med Technologies, Inc.
Quick-Med Technologies, Inc. is a life sciences company that is developing and commercializing proprietary, broad-based technologies for the consumer and healthcare markets. The Company's NIMBUS® technology is the first FDA-cleared, non-leaching antimicrobial technology available in a wound dressing. Its Stay Fresh® technology provides highly durable antimicrobial protection for apparel and other textile applications, with consumer applications of Stay Fresh Technology having EPA registration for the treated articles, as well as an FDA clearance for an antibacterial medical textile product. Quick-Med develops antimicrobial technologies to promote public health, safety and comfort. For more information, see: www.quickmedtech.com.
About Sarasota Medical Products
Sarasota Medical Products Inc. (SMP) develops and manufactures ostomy and advanced wound care products in Sarasota, FL. SMP has a growing portfolio of proprietary technology to drive next-generation product development in the wound, ostomy and incontinence market segments. SMP specializes in gentle and secure adhesive formulations that are suitable for long or short-term skin wear, and is a leader in developing technologies to deliver medication and active oxygen to chronic wounds. As a contract manufacturer and technology development partner, SMP offers creative, collaborative and custom device design services for medical products. Information: www.sarasotamedical.com
© 2014 Quick-Med Technologies, Inc. All rights reserved. NIMBUS®, and Stay Fresh® are registered trademarks of Quick-Med Technologies, Inc.
Forward-looking statements (statements which are not historical facts) in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained in this release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "may", "will", "to", "expect", "plan", "believe", "anticipate", "intend", "could", "would", "estimate", and/or "continue" or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements involve risks and uncertainties, including those risks that are discussed in the Company's filings with the Securities and Exchange Commission ("SEC"), which may be accessed at the SEC's Edgar System at www.sec.gov.
Source: Quick-Med Technologies
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.